Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations

被引:9
|
作者
Nakov, Radislav [1 ]
Suhr, Ole B. [2 ]
Ianiro, Gianluca [3 ]
Kupcinskas, Juozas [4 ,5 ]
Segal, Jonathon P. [6 ]
Dumitrascu, Dan L. [7 ]
Heinrich, Henriette [8 ]
Mikolasevic, Ivana [9 ,10 ]
Stojkovic-Lalosevic, Milica [11 ]
Barbov, Ivan [12 ]
Sarafov, Stayko [13 ]
Tournev, Ivailo [13 ,14 ]
Nakov, Ventsislav [1 ]
Wixner, Jonas [2 ]
机构
[1] Med Univ Sofia, Tsaritsa Joanna Univ Hosp, Dept Gastroenterol, Clin Gastroenterol, Sofia, Bulgaria
[2] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Digest Dis Ctr, Dept Gastroenterol, Rome, Italy
[4] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania
[5] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania
[6] St Marys Hosp, Dept Gastroenterol & Hepatol, London, England
[7] Iuliu Hatieganu Univ Med & Pharm, Dept Internal Med 2, Cluj Napoca, Romania
[8] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland
[9] UH Merkur, Dept Gastroenterol, Zagreb, Croatia
[10] UHC Rijeka, Rijeka, Croatia
[11] Clin Ctr Serbia, Dept Gastroenterol & Hepatol, Belgrade, Serbia
[12] Univ Clin Neurol, Dept Neurol, Skopje, North Macedonia
[13] Med Univ Sofia, Alexandrovska Univ Hosp, Clin Nervous Dis, ATTR Amyloidosis Expert Ctr,Dept Neurol,Expert Ct, Sofia, Bulgaria
[14] New Bulgarian Univ, Dept Cognit Sci & Psychol, Sofia, Bulgaria
关键词
differential diagnosis; rare disease; transthyretin amyloidosis;
D O I
10.1097/MEG.0000000000002030
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transthyretin amyloid (ATTR) amyloidosis is an adult-onset, rare systemic disorder characterized by the accumulation of misfolded fibrils in the body, including the peripheral nerves, the heart and the gastrointestinal tract. Gastrointestinal manifestations are common in hereditary (ATTRv) amyloidosis and are present even before the onset of the polyneuropathy in some cases. Delays in diagnosis of ATTRv amyloidosis with gastrointestinal manifestations commonly occur because of fragmented knowledge among gastroenterologists and general practitioners, as well as a shortage of centers of excellence and specialists dedicated to disease management. Although the disease is becoming well-recognized in the societies of Neurology and Cardiology, it is still unknown for most gastroenterologists. This review presents the recommendations for ATTRv amyloidosis with gastrointestinal manifestations elaborated by a working group of European gastroenterologists and neurologists, and aims to provide digestive health specialists with an overview of crucial aspects of ATTRv amyloidosis diagnosis to help facilitate rapid and accurate identification of the disease by focusing on disease presentation, misdiagnosis and management of gastrointestinal symptoms.
引用
收藏
页码:613 / 622
页数:10
相关论文
共 50 条
  • [1] Identification and management of gastrointestinal manifestations of hereditary transthyretin amyloidosis: Recommendations from an Italian of
    Cappello, Maria
    Barbara, Giovanni
    Bellini, Massimo
    Consalvo, Danilo
    Di Sabatino, Antonio
    Marasco, Giovanni
    Principi, Mariabeatrice
    Savarino, Edoardo Vincenzo
    Tortora, Annalisa
    Obici, Laura
    [J]. DIGESTIVE AND LIVER DISEASE, 2024, 56 (06) : 1014 - 1020
  • [2] Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis
    Bistola, Vasiliki
    Parissis, John
    Foukarakis, Emmanouil
    Valsamaki, Pipitsa N.
    Anastasakis, Aris
    Koutsis, Georgios
    Efthimiadis, Georgios
    Kastritis, Efstathios
    [J]. HEART FAILURE REVIEWS, 2021, 26 (04) : 861 - 879
  • [3] Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis
    Vasiliki Bistola
    John Parissis
    Emmanouil Foukarakis
    Pipitsa N. Valsamaki
    Aris Anastasakis
    Georgios Koutsis
    Georgios Efthimiadis
    Efstathios Kastritis
    [J]. Heart Failure Reviews, 2021, 26 : 861 - 879
  • [4] Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience
    Luigetti, Marco
    Tortora, Annalisa
    Romano, Angela
    Di Paolantonio, Andrea
    Guglielmino, Valeria
    Bisogni, Giulia
    Gasbarrini, Antonio
    Calabresi, Paolo
    Sabatelli, Mario
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (03) : 339 - 343
  • [5] THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease
    Jonas Wixner
    Rajiv Mundayat
    Onur N Karayal
    Intissar Anan
    Pontus Karling
    Ole B Suhr
    [J]. Orphanet Journal of Rare Diseases, 9
  • [6] THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease
    Wixner, Jonas
    Mundayat, Rajiv
    Karayal, Onur N.
    Anan, Intissar
    Karling, Pontus
    Suhr, Ole B.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [7] Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
    Nakov, Radislav
    Sarafov, Stayko
    Nakov, Ventsislav
    Gospodinova, Mariana
    Ianiro, Gianluca
    Todorov, Tihomir
    Todorova, Albena
    Tournev, Ivailo
    [J]. MEDICINE, 2020, 99 (11) : E19509
  • [8] Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis
    Nativi-Nicolau, Jose
    Fine, Nowell M.
    Thomas Ortiz-Perez, Jose
    Brown, Duncan
    Vera-Llonch, Montserrat
    Reddy, Sheila R.
    Chang, Eunice
    Tarbox, Marian H.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (14) : 1031 - 1044
  • [9] GI Manifestations of Transthyretin Amyloidosis
    Elrod, Sarah
    Ginnaram, Shravya
    Marrache, Kyle
    Bosse, Myhanh
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2546 - S2546
  • [10] Recommendations update for the diagnosis and treatment of transthyretin variant amyloidosis (ATTRv)
    Gonzalez-Moreno, Juan
    Davila, Lucia Galan
    Gonzalez-Lopez, Esther
    Conceicao, Isabel
    [J]. MEDICINA CLINICA, 2024, 163 (06): : e69 - e77